Drugs & medicalClass I

Central Admixture Pharmacy Services, Inc. recalls PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), Rx Only, CAPS, Central Admixture Pharmacy…

Presence of Particulate Matter

Read the official notice →
Date
2025-03-19
Country
United States
Brand
Central Admixture Pharmacy Services
Product
PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), Rx Only, CAPS, Central Admixture Pharmacy Services, Inc., 6580…
Classification
Class I
Units
Product was distributed nationwide within the United States
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Central Admixture Pharmacy Services recalls

  1. 2026-08-12
  2. US
  3. 2026-07-01
  4. US
    Drugs & medicalClass II

    Central Admixture Pharmacy Services, Inc. recalls Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Rx# 24-1269856-0-1Compound…

    Incorrect product formulation: bag did not contain copper and famotidine per label.

    FDA · DrugCentral Admixture Pharmacy Services, Inc.MAOfficial notice →
  5. 2023-10-11
  6. US
    Drugs & medicalClass II

    Central Admixture Pharmacy Services Inc recalls fentaNYL, 100 mcg/2 mL, (50 mcg/mL), 3 mL Syringe, Rx only, Repackaged by CAPS Inc., 7935 Dunbrook Road, Suite C, San…

    Lack of assurance of sterility:

    FDA · DrugCentral Admixture Pharmacy Services IncNationwide in the USAOfficial notice →
  7. 2023-09-06
  8. US
    Drugs & medicalClass II

    Central Admixture Pharmacy Services, Inc. recalls EPINEPHrine added to dextrose 5%, 4mg/250ml (16 mcg/mL), IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc.,…

    Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

    FDA · DrugCentral Admixture Pharmacy Services, Inc.Nationwide in the USAOfficial notice →
  9. 2023-08-09
  10. US
    Drugs & medicalClass II

    Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy…

    Lack of assurance of sterility: Lack of validation data for sanitization cycles

    FDA · DrugCentral Admixture Pharmacy Services IncNationwide in the USAOfficial notice →
  11. US
    Drugs & medicalClass II

    Central Admixture Pharmacy Services, Inc. recalls Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 5% with CALCIUM, total volume = 250mL, IV Bag, Rx Only,…

    Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

    FDA · DrugCentral Admixture Pharmacy Services, Inc.Nationwide in the USAOfficial notice →
All 8 Central Admixture Pharmacy Services recalls →

Other drugs & medical recalls in the United States

  1. 2025-03-19
  2. US
  3. US
    Drugs & medicalClass II

    Sigan Industries Group Inc. recalls Walgreens, Acne Control Cleanser, 10% Benzoyl Peroxide/Acne Treatment, NET WT 5 OZ (142g) Distributed by: Walgreen CO, 200 Wilmont…

    Chemical Contamination: Presence of benzene

    FDA · DrugSigan Industries Group Inc.Nationwide in the U.S.AOfficial notice →
  4. US
    Drugs & medicalClass II

    Denison Pharmaceuticals, LLC recalls Zapzyt, Acne Treatment Gel, 10% benzoyl peroxide Gel, packaged in 1 oz (28.35g) tube, Distributed by: FOCUS CONSUMER HEALTHCARE,…

    Chemical Contamination: Presence of benzene.

    FDA · DrugDenison Pharmaceuticals, LLCNationwide within the USAOfficial notice →
  5. US
    Drugs & medicalClass II

    Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L.…

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.

    FDA · DrugBreckenridge Pharmaceutical, Inc.NationwideOfficial notice →
  6. US
    Drugs & medicalClass I

    ICU Medical, Inc. recalls POTASSIUM CHLORIDE Inj., 10 mEq total in 100 mL, 100 mEq/L flexible container, Rx Only, ICU Medical, Inc., Lake Forest, Illinois, 60045,…

    Labeling: Label Error on Declared Strength. Overwrap labeled as Potassium Chloride Inj 10 mEq may contain flexible containers of Potassium Chloride Inj 20 mEq

    FDA · DrugICU Medical, Inc.Nationwide in the USAOfficial notice →
  7. US
    Drugs & medicalClass I

    ICU Medical, Inc. recalls POTASSIUM CHLORIDE Inj., 20 mEq total in 100 mL flexible container 24 x case, 200 mEq/L, Rx Only, ICU Medical, Inc., Lake Forest,…

    Labeling: Label Error on Declared Strength. Cases labeled POTASSIUM CHLORIDE 20 mEq, may contain flexible containers with overwrap mislabeled as 10 mEq. The correct dosage strength of 20 mEq is printed on the labeling…

    FDA · DrugICU Medical, Inc.Nationwide in the USAOfficial notice →
See all drugs & medical recalls →